Phoenix Wealth Advisors’s Fulgent Genetics FLGT Stock Holding History

Phoenix Wealth Advisors’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-50	Closed	-$4K	–	205
2021 Q3	$4K	Buy	+50	New	+$4.54K	﹤0.01%	341

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Phoenix Wealth Advisors's FLGT Position: Q4 2021 in Review

Phoenix Wealth Advisors sold out of Fulgent Genetics (FLGT) in Q4 2021, closing a stake of 50 shares — an estimated $4K sold.

Phoenix Wealth Advisors first reported a position in FLGT in Q3 2021 and held it in 1 quarter. The position peaked at $4K in Q3 2021. 299 funds tracked by Wall St. Rank hold FLGT as of Q4 2021.

Phoenix Wealth Advisors reported no remaining Fulgent Genetics position as of Q4 2021 after selling out during the quarter.
Phoenix Wealth Advisors sold 50 Fulgent Genetics shares in Q4 2021, an estimated $4K.
Phoenix Wealth Advisors first reported a position in Fulgent Genetics in Q3 2021 and held it in 1 quarter.
Phoenix Wealth Advisors's Fulgent Genetics position peaked at $4K in Q3 2021.
299 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2021.

Based on Phoenix Wealth Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.